Delivery Order SPE2DB22D1103-SPE2DB25FH0Q2
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,586.05 for Lidocaine 5% Patch 30s, with an ultimate completion date of August 8, 2025. This non-competitive, firm fixed-price delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, with a contract value of $2,265.72 and an ultimate completion date of August 6, 2025. This competitive award, utilizing firm fixed pricing with no set-aside designation, represents a pharmaceutical supply delivery to support federal healthcare needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,557.69 for Lidocaine 5% Patch (30-count units) on August 19, 2025, with completion targeted for August 20, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and is being performed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,722.08 for Lidocaine 5% Patch 30S on August 1, 2025, with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,504.37 for Lidocaine 5% Patch (30-count units) on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded under open competition. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,920.04 for Lidocaine 5% Patch 30s, with an ultimate completion date of August 21, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,005.35 on August 15, 2025, for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of August 18, 2025. The contract is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Department's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $11,326.93 for Lidocaine 5% patches (30-count packages) on August 4, 2025, with completion expected by August 5, 2025. This firm fixed-price, non-set-aside contract represents a routine pharmaceutical procurement under a larger indefinite delivery contract vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal...
- The Defense Logistics Agency awarded a $3,829.05 delivery order to AmerisourceBergen Drug Corp for 30-count packages of Lidocaine 5% patches. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of July 28, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The contract includes no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at approximately $4.95K to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30-count units. The contract employs firm fixed pricing and carries a completion date of July 31, 2025. This non-set-aside competitive award reflects AmerisourceBergen's ongoing role as a critical pharmaceutical distributor within the federal medical supply chain. The place of performance is located in Conshohocken, Pennsylvania, where the...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB25FH0Q2Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,430.41 for Lidocaine 5% Patch 30s, with an ultimate completion date of August 21, 2025. This is a firm fixed-price, non-set-aside contract utilizing competitive procurement procedures. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This award is part of AmerisourceBergen's comprehensive pharmaceutical and medical supply support to the Defense Logistics Agency's Medical Supply Chain, which serves military healthcare systems and other federal government healthcare organizations. The company's federal contract portfolio demonstrates extensive capability in supplying a broad spectrum of pharmaceutical products, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. The SPE2DX IDC serves as a flexible global pharmaceutical support vehicle enabling AmerisourceBergen to fulfill medical supply needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 8/20/25 |